MAP4K3 and cancer: These results also suggest that the specific inhibition by PKC-θ may effectively suppress cancer cell viability via changes in EP2/EP4 signaling in cases that are quadruple-positive for IGF-1R, EP2 or EP4, MAP4K3, and PKC-θ.